Clinical Trial Update: Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 Patients Have to be Vaccinated MenBVac®

View source ↗

Summary

A clinical trial evaluated the immune response to Neisseria meningitidis serogroup B vaccine MenBVac in 16 participants; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenBVac (Meningococcal B vaccine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Vaccination | Status: COMPLETED